Capital Group Central Fund Series Ii · net assets $11.7B · 805 holdings as of February 28, 2026. Monthly N-PORT disclosure: the full book, not just equities.
DBT: 87.0% · STIV: 12.3% · ABS-O: 0.8% · DCR: 0.0% · DIR: 0.0%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $0 | $0 | $609M |
| Reinvestment | $43.4M | $42.8M | $40.7M |
| Redemptions | $0 | $0 | $80M |
| Net realized gain (non-derivative) | $6.94M | $-1.53M | $8.82M |
| Net unrealized appreciation (non-derivative) | $-97.2M | $-14.1M | $108M |
The three months of the reporting period, as filed; month 3 ends February 28, 2026.
| Tenor | Investment grade | Non-investment grade |
|---|---|---|
| 3 months | $-13.9K | $-16.7 |
| 1 year | $-374K | $-21.4K |
| 5 years | $-2.07M | $-428K |
| 10 years | $-3.12M | $-3.25K |
| 30 years | $-1.49M | $0 |
| Holding | Value | % of net assets |
|---|---|---|
| Capital Group Central Cash Fund STIV | $1.48B | 12.61% |
| United States Treasury DBT | $314M | 2.68% |
| United States Treasury DBT | $243M | 2.07% |
| United States Treasury DBT | $153M | 1.31% |
| Bank Of America Corp DBT | $99.1M | 0.84% |
| Bank Of America Corp DBT | $93.8M | 0.80% |
| Morgan Stanley DBT | $89.5M | 0.76% |
| Abbott Laboratories DBT | $84.9M | 0.72% |
| Chubb Ina Holdings LLC DBT | $80M | 0.68% |
| Bristol-myers Squibb Co DBT | $79.7M | 0.68% |
| Morgan Stanley DBT | $77.4M | 0.66% |
| Pacific Gas And Electric Co DBT | $72.7M | 0.62% |
| New Economy Assets - Phase I Issuer LLC Usre_21-1 ABS-O | $72.6M | 0.62% |
| Takeda Us Financing Inc DBT | $71.3M | 0.61% |
| Abbvie Inc DBT | $69.6M | 0.59% |
| Jpmorgan Chase & Co DBT | $64.7M | 0.55% |
| Oracle Corp DBT | $63.7M | 0.54% |
| Marsh & Mclennan Companies Inc DBT | $62.4M | 0.53% |
| Pfizer Investment Enterprises Pte Ltd DBT | $62.4M | 0.53% |
| Amgen Inc DBT | $59.4M | 0.51% |
| Mars Inc DBT | $56.2M | 0.48% |
| Pacific Gas And Electric Co DBT | $54.9M | 0.47% |
| Boston Properties LP DBT | $53M | 0.45% |
| Amgen Inc DBT | $51.3M | 0.44% |
| Jpmorgan Chase & Co DBT | $49.2M | 0.42% |
| Bae Systems PLC DBT | $48.6M | 0.41% |
| Florida Power & Light Co DBT | $48.3M | 0.41% |
| Bat Capital Corp DBT | $47.5M | 0.41% |
| Jpmorgan Chase & Co DBT | $47M | 0.40% |
| Wells Fargo & Co DBT | $46.5M | 0.40% |
| United States Treasury DBT | $45.9M | 0.39% |
| Intel Corp DBT | $45.5M | 0.39% |
| Charter Communications Operating LLC DBT | $45.5M | 0.39% |
| Bristol-myers Squibb Co DBT | $44.4M | 0.38% |
| Baxter International Inc DBT | $43.8M | 0.37% |
| Goldman Sachs Group Inc DBT | $43.7M | 0.37% |
| Unitedhealth Group Inc DBT | $43.5M | 0.37% |
| Eli Lilly And Co DBT | $43.1M | 0.37% |
| Goldman Sachs Group Inc DBT | $42M | 0.36% |
| Charter Communications Operating LLC DBT | $41.8M | 0.36% |
| Oracle Corp DBT | $41.8M | 0.36% |
| Arthur J Gallagher & Co DBT | $41M | 0.35% |
| AT&T Inc DBT | $41M | 0.35% |
| Starbucks Corp DBT | $40.5M | 0.35% |
| Bpce Sa DBT | $40M | 0.34% |
| Hsbc Holdings PLC DBT | $39.8M | 0.34% |
| Synopsys Inc DBT | $39.8M | 0.34% |
| Home Depot Inc DBT | $38.3M | 0.33% |
| Deutsche Bank Ag (new York Branch) DBT | $37.8M | 0.32% |
| Amgen Inc DBT | $37.7M | 0.32% |
| Gilead Sciences Inc DBT | $37.5M | 0.32% |
| General Electric Co Aka Ge Aerospace DBT | $37.5M | 0.32% |
| Amazon.com Inc DBT | $37.2M | 0.32% |
| Morgan Stanley DBT | $37M | 0.32% |
| Canadian Pacific Railway Co DBT | $36.8M | 0.31% |
| Citigroup Inc DBT | $36.5M | 0.31% |
| Mars Inc DBT | $35.8M | 0.31% |
| Verizon Communications Inc DBT | $35.6M | 0.30% |
| Jpmorgan Chase & Co DBT | $35.4M | 0.30% |
| Aon North America Inc DBT | $35.4M | 0.30% |
Showing top 60 of 805 holdings.
Loading...
